• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]


Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





NO
     
ABMD [ Abiomed Inc ]
Last Trade 317.0 Date 8/6/2020
Change % 3.82 % Price Change 11.65
Open 305.36 52 Week High 310.969
High 319.19 52 Week Low 119.0101
Low 303.11 Type stock
Volume 466674 Average Volume 858455
Prev Close 305.35 Stock Exchange NASDAQ
Bid 317.0 Ask 325.0
Bid Size 1 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 23.6538 Book Value Yield 0.0775
Buy Back Yield 0.0062 CAPE Ratio 169.0866
Cash Return 0.0204 Cash Flow per Share 6.8736
Cash Flow Yield 0.0225 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield 0.0145 EV/EBIT 53.4113
EV/EBITDA 49.3646 EV / Free Cash Flow 49.1341
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income 51.8295
EV / Revenue 15.8299 EV / Total Asset 10.9425
Expected Dividend Growth Rate Free Cash Flow per Share 5.9131
Free Caash Flow Ratio 51.639692 Free Cash Flow Yield 0.0194
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio 72.354288 Payout Ratio 0.0
PB Ratio 12.909121 PB Ratio 10 Year Growth 0.123782
PB Ratio 3 Year Growth 14.898026 Cash Ratio 3 Year Average 3082.0713
Price to Cash Flow Ratio 44.423713 PEG Payback
PEG Ratio PE Ratio 68.927765
PE Ratio 10 Year Average 103.450011 PE Ratio 10 Year Growth
PE Ratio 10 Year High 615.5 PE Ratio 10 Year Low 22.513208
PE Ratio 1 Year Avg 39.575053 PE Ratio 1 Year High 69.604966
PE Ratio 1 Year Low 24.485929 PE Ratio 3 Year Avg 79.105736
PE Ratio 5 Year Avg 82.065054 PE Ratio 5 Year High 182.126531
PE Ratio 5 Year Low 23.703704 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 80.928 Price Change 1 Month 1.018037
Price to Cash Ratio 31.039795 Price / EBITDA 51.881949
Price to Sales Ratio 16.637173 Price to Sales Ratio 10 Year Growth 0.141585
Price to Sales Ratio 3 Year Avg 17.971234 Price to Sales Ratio 5 Year Avg 82.065054
Sale per Share 18.3535 Sales Yield 0.0601
Sustainable Growth Rate 0.2028 Tangible Book Value per Share 22.613
Tangible Book Value per Share 3 year Avg 16.6575 Tangible Book Value per Share 5 year Avg 12.941
Total Asset per Share 27.006 Total Yield 0.0062
Working Capital per Share 11.1885 Working Capital per Share 3 Year Avg 9.8128
Working Capital per Share 5 Year Avg 8.2078 Beta 1.356855
Company Profile

Abiomed, Inc. and its subsidiaries manufacture and sell medical devices in circulatory support that offer a continuum of care in heart recovery to acute heart failure patients. It offers various disposable products for the surgery suite, which comprise BVS 5000 blood pump and AB5000 ventricle for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis; integrated cannula system that connects the ventricle or blood pump to the heart and an associated artery; and Impella LD that provides temporary left ventricular assist devices support for recovery from post-cardiotomy hemodynamic instability and cardiogenic shock. The company also provides disposable products for the cardiac catheterization lab and the surgery suite that include Impella 2.5 and 5.0 catheters, which are percutaneous micro heart pumps with integrated motors and sensors for use in interventional cardiology and heart surgery; and IAB, a percutaneous intra-aortic balloon used to support various prophylactic, pre-shock, and profound shock conditions. In addition, it offers driver console products, such as AB5000 console for BVS 5000 blood pump and AB5000 ventricle; mobile pump consoles for Impella products; iPulse console, a multi-purpose driver console for IAB, AB5000, BVS 5000, and other manufacturers? IABs; and portable discharge driver for AB5000 for in-hospital and out-of-hospital patients. Further, Abiomed provides AbioCor implantable replacement heart, a self-contained artificial heart for severe biventricular heart failure. It sells its products through direct sales representatives and clinical support personnel in the United States, Germany, France, the United Kingdom, and Ireland; and internationally. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.